Shares of HIMS experienced a dramatic slump today following the unexpected withdrawal of its deal with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending HIMS's stock price plummeting by more than 20%. The reason for the dissolution of the partnership remains unclear, but industry analysts speculate that it could